Eurocode-IBLS Homepage Product Codes Qualifier Unframe
Product Groups A B C D E F G H I K L M N O P Q T V
Release 1.7.22Description History

Q: Additional testing / quarantine

Additional/secondary testing of donors/products for risk reduction of pathogen transmission. Requirements see as specified by national regulations.
0
1.7.15
Not specified
?
May have been subject to quarantine and/or additional testing either listed below or not. See accompanying documents for details.
1
1.4.1; 1.7.20
No quarantine
None
Including blood products with serological and highly sensitive nucleic acid amplification technology testing on viruses according to current regulations (e.g. for Germany decision of the PEI "Prevention of drug risks, Graduated plan level 2" of April 5th, 2023)
2
1.4.1; 1.7.15
Quarantine
Qu
Secondary testing at the end of a quarantine period according to current local regulations or approved study protocols. See "Guide to the Preparation, Use and Quality Assurance of Blood Components".
Up to rel. 1.7.12: "Quarantine according to current local regulations. See 'Guide to the Preparation, Use and Quality Assurance of Blood Components'".
10
1.7.13
Tested negative for bacteria
BactTestNeg
Product was tested negative for bacterial contamination

| Copyright | Disclaimer | Edition 2024-04-25T05:56 UTC from Eurocode-IBLS Database 2024-03-05ff
Safe script-free high performance website - Optimised for any browser and any resolution